促甲状腺激素与临床相关抑郁的关联:一项回顾性横断面研究
本研究为回顾性横断面研究,纳入2016年10月至2021年5月在犹他大学健康中心连续就诊、年龄≥18岁且6个月内完成TSH检测和PHQ-9问卷的成人33138例,分析TSH与临床相关抑郁(PHQ-9≥10)的关联。结论认为甲状腺功能障碍与抑郁风险升高相关,建议未来开展纵向队列研究。
要点
- 作者建议未来开展纵向队列研究探讨甲状腺功能与抑郁发病的关联。
核心结论
- 甲状腺功能障碍与抑郁风险升高相关,未来建议开展纵向队列研究探讨甲状腺功能与抑郁发病的关联。
研究设计与样本
- 回顾性横断面研究,纳入2016年10月至2021年5月在犹他大学健康中心连续就诊、年龄≥18岁且6个月内完成TSH检测和PHQ-9问卷的成人,共33138例。
主要发现
- 队列平均年龄42.41±16.10岁,80.67%为白人,69.10%为女性,平均PHQ-9评分为10.11±6.94。
- 45.23%(n=14989)的患者有情绪障碍诊断,49.70%存在临床相关抑郁(PHQ-9≥10)。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Introduction: Thyroid dysfunction and mood disorders are chronic health conditions with a significant impact on quality of life. This study aimed to investigate the association between thyrotropin (TSH) and clinically relevant depression (CRD) in patients with and without mood disorders, in a population-based sample. Methods: This retrospective cross-sectional study included all consecutive adults (≥18 years) who had TSH and completed the Patient Health Questionnaire (PHQ-9) within 6 months of the index visit, between October 2016 and May 2021, at the University of Utah Health. Data on demographics, hypothyroidism diagnoses, TSH, thyroid hormone replacement (THR), PHQ-9, antidepressant (AD) medications, and mood disorder diagnoses (using the International Classification of Diseases, 10th Revision, Clinical Modification codes; Major depressive disorder single episode-F32, recurrent-F33, persistent mood disorder-F34, bipolar disorder-F30+F31, and mood disorder not otherwise specified-F39) were extracted electronically. CRD was defined as PHQ-9 ≥ 10. t-Test and chi-square test were used to compare continuous and categorical variables, respectively. Logistic regression models were formulated to evaluate the association between TSH and CRD, after adjusting for covariates. Results: The cohort included 33,138 patients, mean age 42.41 ± 16.10 years, 80.67% Caucasian, 69.10% females, and mean PHQ-9 score 10.11 ± 6.94. A total of 45.23% (n = 14,989) patients had a diagnosis of mood disorders, and 49.70% had CRD. Patients with mood disorders were more likely to be female, Caucasian, non-Hispanic/Latino, on AD, had hypothyroidism diagnoses, on thyroid medications, had higher mean PHQ-9 scores, and had CRD. TSH level was associated with an increased odds of CRD (odds ratio [OR] = 1.01, confidence interval [CI], 1.01-1.02, p < 0.009) after adjusting for age, sex, body mass index, Charlson Comorbidity Index, and use of THR and AD. Both the low TSH and high TSH groups showed increased odds of CRD, with respective ORs of 1.19 (CI: 1.04-1.37) and 1.26 (CI: 1.13-1.40). Conclusions: Thyroid dysfunction is associated with an increase in the odds of depression. Future longitudinal cohort studies are recommended to investigate the association between thyroid function and incident depression.
引用
- Singh B, Bakian AV, Newman M, et al. The Association Between Thyrotropin and Clinically Relevant Depression: A Retrospective Cross-Sectional Study. Thyroid. 2025. PMID: 39909475. doi:10.1089/thy.2024.0428
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。